Company Summary
Search
Home Page
 
Theralase Technologies Inc. 
Listed Company 
Current   Past  
Fiscal Year EndCompany StatusExempt Flag
December 31TradingN
Incorporation Locations
Inc. DateExpiry DateCountryRegionDescription
22/Aug/1989  Canada   
Exchange Filing Office
Location
Toronto Regional Service Office
Business Type(s)
Primary/SecondaryBusiness TypeDetails
Primary  Medical Device Development  And Marketing 
Securities
SymbolSecurity NameMarketStatus
TLTTheralase Technologies Inc.TSX VentureTRADING
TLT.WTTheralase Technologies Inc. wt 22Aug2024TSX VentureTRADING
Name HistoryFromTo
Theralase Technologies Inc.2/Nov/2004Present
Company Facts Reconciliation
SubjectDate Returned
Spring 2015 CFR Not Received
Associations
Auditing Firm:  Collins Barrow Toronto LLP
Auditor:  Collins Barrow
Investor Relations:  The Equicom Group Inc.
Law Firm:  Minden Gross LLP Toronto
Subsidiary:  Theralase Biotech Inc.
  Theralase Inc.
Transfer Agent:  TSX Trust Company
Latest Information
TypeDateTitle
News Releases  9/Oct/2018  NEWS RELEASE - ANTI CANCER TECHNOLOGY SHOWS PROMISE FOR ESOPHAG[MARKET NEWS]
    NEWS RELEASE - COMPLETION OF NON BROKERED PRIVATE PLACEMENT OF[MARKET NEWS]
    NEWS RELEASE - DISCOVERS CANNABINOID INCREASES EFFICACY OF PATE[MARKET NEWS]
Bulletins  14/May/2020  Warrant Term Extension
Meetings and Public Filings  Information on financial statements, public filings and corporate meetings for all Canadian public companies can be found at www.sedar.com
Property Locations
(not available)

* Historical Data